Alkermes ALKS
NASDAQ ALKS
$43.63 -0.55 (-1.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Alkermes (ALKS) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Alkermes (ALKS) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Alkermes 7.31 Bn 4.44 Bn 397.90 Mn 20.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.09 Mn
Mar 31, 2026 42.61 Mn
Dec 31, 2025 377.11 Mn
Sep 30, 2025 125.31 Mn
Jun 30, 2025 81.59 Mn
Mar 31, 2025 113.49 Mn
Dec 31, 2024 85.50 Mn
Sep 30, 2024 85.84 Mn
Jun 30, 2024 56.46 Mn
Mar 31, 2024 82.49 Mn
Dec 31, 2023 63.58 Mn
Sep 30, 2023 51.40 Mn
Jun 30, 2023 136.94 Mn
Mar 31, 2023 103.61 Mn
Dec 31, 2022 90.63 Mn
Sep 30, 2022 81.07 Mn
Jun 30, 2022 49.15 Mn
Mar 31, 2022 60.78 Mn
Dec 31, 2021 53.93 Mn
Sep 30, 2021 65.58 Mn
API Access

Alkermes Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALKS&period=max&api_key=YOUR_API_KEY